VANI vs. FONR, OM, HYPR, ELMD, PXDT, ECOR, POCI, MOVE, SMLR, and EDAP
Should you be buying Vivani Medical stock or one of its competitors? The main competitors of Vivani Medical include FONAR (FONR), Outset Medical (OM), Hyperfine (HYPR), Electromed (ELMD), Pixie Dust Technologies (PXDT), electroCore (ECOR), Precision Optics (POCI), Movano (MOVE), Semler Scientific (SMLR), and Edap Tms (EDAP). These companies are all part of the "electromedical equipment" industry.
Vivani Medical (NASDAQ:VANI) and FONAR (NASDAQ:FONR) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, earnings, profitability, dividends, analyst recommendations, community ranking, risk, media sentiment and institutional ownership.
FONAR received 168 more outperform votes than Vivani Medical when rated by MarketBeat users. However, 100.00% of users gave Vivani Medical an outperform vote while only 73.48% of users gave FONAR an outperform vote.
FONAR has a net margin of 12.63% compared to Vivani Medical's net margin of 0.00%. FONAR's return on equity of 8.47% beat Vivani Medical's return on equity.
Vivani Medical has a beta of 3.26, meaning that its stock price is 226% more volatile than the S&P 500. Comparatively, FONAR has a beta of 1.12, meaning that its stock price is 12% more volatile than the S&P 500.
In the previous week, Vivani Medical and Vivani Medical both had 2 articles in the media. FONAR's average media sentiment score of 1.13 beat Vivani Medical's score of 0.50 indicating that FONAR is being referred to more favorably in the news media.
6.8% of Vivani Medical shares are owned by institutional investors. Comparatively, 50.6% of FONAR shares are owned by institutional investors. 55.6% of Vivani Medical shares are owned by company insiders. Comparatively, 2.2% of FONAR shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
FONAR has higher revenue and earnings than Vivani Medical. Vivani Medical is trading at a lower price-to-earnings ratio than FONAR, indicating that it is currently the more affordable of the two stocks.
Summary
FONAR beats Vivani Medical on 10 of the 13 factors compared between the two stocks.
Get Vivani Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for VANI and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding VANI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Vivani Medical Competitors List
Related Companies and Tools
